Regenerative Medicine and Stem Cells Technologies

Chinese scientists claim to have engineered the world's first mouse with fully reprogrammed genes

• Aug 31 2022 - 16:08

Verismo Looks to Assess KIR-CAR Cell Therapy in Solid Tumors

• Aug 30 2022 - 14:29

Vasculogenesis in kidney organoids upon transplantation

• Aug 30 2022 - 12:16

mRNA Cancer Vaccine Elicits T Cell Response and Eliminates Tumors in Mice

• Aug 29 2022 - 15:28

Non-viral CRISPR could overcome cell and gene therapy bottlenecks

• Aug 29 2022 - 12:23

Novartis' T-Charge Platform Spotlights Auto CAR-Ts

• Aug 28 2022 - 16:04

You don’t have search long and hard for news in the CGT sector about companies concentrating on developing and manufacturing allogeneic, or off-the-shelf- therapies. Take Poseida Therapeutics for example.

Outcomes of two-step haploidentical allogeneic stem cell transplantation in elderly patients with hematologic malignancies

• Aug 28 2022 - 15:52

Improving the differentiation potential of pluripotent stem cells by optimizing culture conditions

• Aug 27 2022 - 15:58

Gene Therapy for Completely Color Blind Children Partly Restores Cone Function

• Aug 27 2022 - 13:13

FDA grants fast track designation to CD33-directed CAR-T for acute myeloid leukemia

• Aug 27 2022 - 09:10